- Home
- WFRD vs ICLR Comparison
WFRD vs ICLR Comparison
Compare WFRD & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WFRD | ICLR |
|---|---|---|
| Founded | 1941 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.1B |
| IPO Year | 2014 | 2001 |
Fundamental Metrics
Financial Performance| Metric | WFRD | ICLR |
|---|---|---|
| Price | $96.87 | $100.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $98.33 | ★ $182.08 |
| AVG Volume (30 Days) | ★ 1.4M | 944.2K |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.93 | N/A |
| Revenue | ★ $4,331,000,000.00 | N/A |
| Revenue This Year | $0.39 | N/A |
| Revenue Next Year | $3.97 | N/A |
| P/E Ratio | $15.69 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.74 | $66.57 |
| 52 Week High | $110.57 | $211.00 |
Technical Indicators
Market Signals| Indicator | WFRD | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 57.82 | 38.35 |
| Support Level | $82.88 | $66.57 |
| Resistance Level | $108.48 | $113.88 |
| Average True Range (ATR) | 4.19 | 4.35 |
| MACD | 0.49 | 1.98 |
| Stochastic Oscillator | 99.93 | 31.11 |
Price Performance
Historical ComparisonAbout WFRD Weatherford International plc
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.